PAR 12.7% 31.0¢ paradigm biopharmaceuticals limited..

Valuation and Targets, page-355

  1. 4,213 Posts.
    lightbulb Created with Sketch. 6695
    Yeah I kinda suspected...hence the 2023 comment.. its not all bad is my thought though, it could've been worse.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.